Drug-induced impulse control disorders: A prospectus for neuroethical analysis

Neuroethics

Volumn 4, Issue 2, 2011, Pages 91-102

  Carter, Adrian ^a,b   Ambermoon, Polly ^a,b   Hall, Wayne D ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Addiction; Dopamine agonists; Impulse control disorders; Moral responsibility; Neuroethics; Parkinson's Disease

Indexed keywords

CABERGOLINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METHYLPHENIDATE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADDICTION; ARTICLE; ATTENTION DEFICIT DISORDER; COMPREHENSION; CRIMINAL BEHAVIOR; DECISION MAKING; DRUG DEPENDENCE; DRUG INDUCED DISEASE; ETHICS; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; NEUROBIOLOGY; NEUROPSYCHOLOGY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RESPONSIBILITY;

EID: 79960461091     PISSN: 18745490     EISSN: 18745504     Source Type: Journal    
DOI: 10.1007/s12152-010-9071-7     Document Type: Article

References (90)

1. MN Potenza V Voon D Weintraub 2007 Drug Insight: Impulse control disorders and dopamine therapies in Parkinson's disease Nature Clinical Practice Neurology 3 664 672 10.1038/ncpneuro0680 (Pubitemid 350238058)
2. TE Kimber PD Thompson MA Kiley 2008 Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease Journal of Clinical Neuroscience 15 205 208 10.1016/j.jocn.2006.04.019 (Pubitemid 50009897)
3. B Kolla 2009 Pathological gambling in patients on pramipexole for restless legs syndrome: A case series and review of the current literature Sleep Medicine Reviews 32 A34
4. Whitehead, L. 2008. Patients to launch class action over Parkinson's drug. ABC News. http://www.abc.net.au/news/stories/2008/01/22/2143502.htm. Accessed 22 January 2008.
5. McDermott, N. 2008. Ex-headmaster found with child porn is freed after blaming Parkinson's drug. The Daily Mail, 12 September. http://www.dailymail.co. uk/news/article-1054748/Ex-headmaster-child-porn-freed-blaming-Parkinsons-drug. html. Accessed 9 December 2009.
6. A Cannas P Solla G Floris P Tacconi D Loi E Marcia MG Marrosu 2006 Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 1539 1541 10.1016/j.pnpbp.2006.05.012 (Pubitemid 44634949)
7. JM Ferrara M Stacy 2008 Impulse-control disorders in Parkinson's disease CNS Spectrums 13 690 698
8. AD Lawrence AH Evans AJ Lees 2003 Compulsive use of dopamine replacement therapy in Parkinson's disease: Reward systems gone awry? Lancet Neurology 2 595 604 10.1016/S1474-4422(03)00529-5 (Pubitemid 37162568)
9. JB Rowe L Hughes BC Ghosh D Eckstein CH Williams-Gray S Fallon RA Barker AM Owen 2008 Parkinson's disease and dopaminergic therapy: Differential effects on movement, reward and cognition Brain 131 2094 2105 10.1093/brain/awn112
10. AF Leentjens J Koester B Fruh DT Shephard P Barone JJ Houben 2009 The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: A meta-analysis of placebo-controlled studies Clinical Therapeutics 31 89 98 10.1016/j.clinthera.2009.01.012
11. DA Copland KL McMahon PA Silburn GI de Zubicaray 2009 Dopaminergic neuromodulation of semantic processing: A 4-T fMRI study with levodopa Cerebral Cortex 19 2651 2658 10.1093/cercor/bhp017
12. U Kischka T Kammer S Maier M Weisbrod M Thimm M Spitzer 1996 Dopaminergic modulation of semantic network activation Neuropsychologia 34 1107 1113 10.1016/0028-3932(96)00024-3 (Pubitemid 26345288)
13. A Dagher TW Robbins 2009 Personality, addiction, dopamine: Insights from Parkinson's disease Neuron 61 502 510 10.1016/j.neuron.2009.01.031
14. AR Damasio J Lobo-Antunes C Macedo 1971 Psychiatric aspects in Parkinsonism treated with L-dopa Journal of Neurology, Neurosurgery and Psychiatry 34 502 507 10.1136/jnnp.34.5.502
15. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders-text revision (DSM-IV-TR). Washington: APA.
16. DA Gallagher SS O'Sullivan AH Evans AJ Lees A Schrag 2007 Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series Movement Disorders 22 1757 1763 10.1002/mds.21611 (Pubitemid 47597599)
17. V Voon MN Potenza T Thomsen 2007 Medication-related impulse control and repetitive behaviors in Parkinson's disease Current Opinion in Neurology 20 484 492 10.1097/WCO.0b013e32826fbc8f (Pubitemid 47051998)
18. D Weintraub MN Potenza 2006 Impulse control disorders in Parkinson's disease Current Neurology and Neuroscience Reports 6 302 306 10.1007/s11910-006-0022-y (Pubitemid 44069969)
19. ML Dodd KJ Klos JH Bower YE Geda KA Josephs JE Ahlskog 2005 Pathological gambling caused by drugs used to treat Parkinson disease Archives of Neurology 62 1377 1381 10.1001/archneur.62.9.noc50009 (Pubitemid 41352054)
20. V Voon K Hassan M Zurowski M de Souza T Thomsen S Fox AE Lang J Miyasaki 2006 Prevalence of repetitive and reward-seeking behaviors in Parkinson disease Neurology 67 1254 1257 10.1212/01.wnl.0000238503.20816.13 (Pubitemid 44563838)
21. D Weintraub AD Siderowf MN Potenza J Goveas KH Morales JE Duda PJ Moberg MB Stern 2006 Association of dopamine agonist use with impulse control disorders in Parkinson disease Archives of Neurology 63 969 973 10.1001/archneur.63.7.969 (Pubitemid 44036299)
22. KJ Klos JH Bower KA Josephs JY Matsumoto JE Ahlskog 2005 Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy Parkinsonism and Related Disorders 11 381 386 10.1016/j.parkreldis.2005.06.005 (Pubitemid 41317806)
23. M Sensi R Eleopra MA Cavallo E Sette P Milani R Quatrale JG Capone V Tugnoli MR Tola E Granieri PG Data 2004 Explosive-aggressive behavior related to bilateral subthalamic stimulation Parkinsonism and Related Disorders 10 247 251 10.1016/j.parkreldis.2004.01.007 (Pubitemid 38534619)
24. A Fasano AE Elia F Soleti A Guidubaldi AR Bentivoglio 2006 Punding and computer addiction in Parkinson's disease Movement Disorders 21 1217 1218 10.1002/mds.20787 (Pubitemid 44336611)
25. MJ Nirenberg C Waters 2006 Compulsive eating and weight gain related to dopamine agonist use Movement Disorders 21 524 529 10.1002/mds.20757
26. G Giovannoni JD O'Sullivan K Turner AJ Manson AJL Lees 2000 Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies Journal of Neurology, Neurosurgery and Psychiatry 68 423 428 10.1136/jnnp.68.4.423 (Pubitemid 30248740)
27. LL Borek JH Friedman 2005 Levodopa addiction in idiopathic Parkinson disease Neurology 65 1508 10.1212/01.wnl.0000183147.59483.ab (Pubitemid 41552800)
28. Weintraub, D., J. Koester, M. Potenza, A. Siderowf, M. Stacy, V. Voon, J. Whetteckey, G. Wunderlich, and A. Lang. 2010. Impulse control disorders in Parkinson's disease: A cross-sectional study of dopaminergic therapy and other clinical features in 3,090 patients. Archives of Neurology (in press).
29. Rabinak, C.A., and M.J. Nirenberg. 2010. Dopamine agonist withdrawal syndrome in Parkinson disease. Archives of Neurology 67: 58-63.
30. Hill, A. 1977. A short textbook of statistics. London: Hodder and Stoughton.
31. Weintraub, D. 2009. Impulse control disorders in Parkinson's disease: Prevalence and possible risk factors. Parkinsonism and Related Disorders 15: S110-113.
32. RC Kessler PM Berglund OM Demler RM Jin EE Walters 2005 Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Archives of General Psychiatry 62 593 602 10.1001/archpsyc.62.6.593 (Pubitemid 40973434)
33. RC Kessler EF Coccaro M Fava S Jaeger R Jin E Walters 2006 The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication Archives of General Psychiatry 63 669 678 10.1001/archpsyc.63.6.669 (Pubitemid 43848298)
34. NM Petry FS Stinson BF Grant 2005 Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: Results from the national epidemiologic survey on alcohol and related conditions The Journal of Clinical Psychiatry 66 564 574 10.4088/JCP.v66n0504 (Pubitemid 40733697)
35. M Avanzi M Baratti S Cabrini E Uber G Brighetti F Bonfa 2006 Prevalence of pathological gambling in patients with Parkinson's disease Movement Disorders 21 2068 2072 10.1002/mds.21072 (Pubitemid 46140413)
36. V Voon K Hassan M Zurowski S Duff-Canning M de Souza S Fox AE Lang J Miyasaki 2006 Prospective prevalence of pathologic gambling and medication association in Parkinson disease Neurology 66 1750 1752 10.1212/01.wnl. 0000218206.20920.4d (Pubitemid 43964638)
37. N Bodi S Keri H Nagy A Moustafa CE Myers N Daw G Dibo A Takats D Bereczki MA Gluck 2009 Reward-learning and the novelty-seeking personality: A between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients Brain 132 2385 2395 10.1093/brain/awp094
38. AH Evans AD Lawrence J Potts L MacGregor R Katzenschlager K Shaw J Zijlmans AJ Lees 2006 Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease Journal of Neurology, Neurosurgery and Psychiatry 77 317 321 10.1136/jnnp.2005.065417
39. AH Evans H Butzkueven 2007 Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis Movement Disorders 22 590 591 10.1002/mds.21303 (Pubitemid 46608168)
40. M Tippmann-Peikert JG Park BF Boeve JW Shepard MH Silber 2007 Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists Neurology 68 301 303 10.1212/01.wnl.0000252368.25106.b6 (Pubitemid 46148346)
41. ED Driver-Dunckley BN Noble JG Hentz VG Evidente JN Caviness J Parish L Krahn CH Adler 2007 Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome Clinical Neuropharmacology 30 249 255 10.1097/wnf.0b013e31804c780e (Pubitemid 47511504)
42. AJ Holman 2009 Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia Journal of Gambling Studies 25 425 431 10.1007/s10899-009-9123-2
43. H Falhammar JY Yarker 2009 Pathological gambling and hypersexuality in cabergoline-treated prolactinoma The Medical Journal of Australia 190 97
44. E Driver-Dunckley J Samanta M Stacy 2003 Pathological gambling associated with dopamine agonist therapy in Parkinson's disease Neurology 61 422 423 (Pubitemid 36975988)
45. V Voon SH Fox 2007 Medication-related impulse control and repetitive behaviors in Parkinson disease Archives of Neurology 64 1089 1096 10.1001/archneur.64.8.1089 (Pubitemid 47258066)
46. N Giladi N Weitzman S Schreiber H Shabtai C Peretz 2007 New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: The role of dopamine agonist treatment and age at motor symptoms onset Journal of Psychopharmacology 21 501 506 10.1177/0269881106073109 (Pubitemid 47106924)
47. V Voon T Thomsen JM Miyasaki M de Souza A Shafro SH Fox S Duff-Canning AE Lang M Zurowski 2007 Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease Archives of Neurology 64 212 216 10.1001/archneur.64.2.212
48. M Zack CX Poulos 2009 Parallel roles for dopamine in pathological gambling and psychostimulant addiction Current Drug Abuse Reviews 2 11 25 10.2174/1874473710902010011
49. D Merims N Giladi 2008 Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease Parkinsonism and Related Disorders 14 273 280 10.1016/j.parkreldis.2007.09.007 (Pubitemid 351736001)
50. LI Varga N Ako-Agugua J Colasante L Hertweck T Houser J Smith AA Watty S Nagar RB Raffa 2009 Critical review of ropinirole and pramipexole-putative dopamine D(3)-receptor selective agonists-for the treatment of RLS Journal of Clinical Pharmacy and Therapeutics 34 493 505 10.1111/j.1365-2710.2009.01025.x
51. B Ata A Seyhan S Orhaner B Urman 2009 High dose cabergoline in management of ovarian hyperstimulation syndrome Fertility and Sterility 92 1168 e1161 e1164
52. ZX Xi EL Gardner 2008 Hypothesis-driven medication discovery for the treatment of psychostimulant addiction Current Drug Abuse Reviews 1 303 327 10.2174/1874473710801030303
53. EA Fridman J Calvar M Bonetto E Gamzu BZ Krimchansky F Meli RC Leiguarda R Zafonte 2009 Fast awakening from minimally conscious state with apomorphine Brain Injury 23 172 177 10.1080/02699050802649662
54. E Sawyer LS Mauro MJ Ohlinger 2008 Amantadine enhancement of arousal and cognition after traumatic brain injury The Annals of Pharmacotherapy 42 247 252 10.1345/aph.1K284 (Pubitemid 351238573)
55. P Gontero R D'Antonio G Pretti F Fontana M Panella E Kocjancic G Allochis B Frea 2005 Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men International Journal of Impotence Research 17 80 85 10.1038/sj.ijir.3901273 (Pubitemid 40299998)
56. N Clausius C Born H Grunze 2009 The relevance of dopamine agonists in the treatment of depression Neuropsychiatrie 23 15 25
57. F Akdeniz E Aldemir S Vahip 2009 The role of low-dose pramipexole in the treatment of treatment-resistant bipolar depression: A case report Türk Psikiyatri Dergisi 20 94 98
58. N Simakajornboon L Kheirandish-Gozal D Gozal 2009 Diagnosis and management of restless legs syndrome in children Sleep Medicine Reviews 13 149 156 10.1016/j.smrv.2008.12.002
59. MA Harris 2009 Too soon for dopaminergics in the management of restless legs syndrome in children Sleep Medicine Reviews 13 299 300 10.1016/j.smrv.2009. 03.002
60. D Weintraub S Hoops JA Shea KE Lyons R Pahwa ED Driver-Dunckley CH Adler MN Potenza J Miyasaki AD Siderowf JE Duda HI Hurtig A Colcher SS Horn MB Stern V Voon 2009 Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease Movement Disorders 24 1461 1467 10.1002/mds.22571
61. Feinberg, J. 1996. Reason and responsibility: Readings in some basic problems of philosophy, 9th ed. Belmont: Wadsworth.
62. LC Charland 2002 Cynthia's dilemma: Consenting to heroin prescription The American Journal of Bioethics 2 37 47 10.1162/152651602317533686
63. A Carter W Hall 2008 The issue of consent in research that administers drugs of addiction to addicted persons Accountability in Research 15 209 225 10.1080/08989620802388689
64. RP Munhoz G Fabiani N Becker HA Teive 2009 Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: A case report The Journal of Sexual Medicine 6 1177 1180 10.1111/j.1743-6109.2008.00861.x
65. I Singh 2007 Clinical implications of ethical concepts: Moral self-understandings in children taking methylphenidate for ADHD Clinical Child Psychology and Psychiatry 12 167 182 10.1177/1359104507075920 (Pubitemid 46669120)
66. I Singh 2005 Will the "real boy" please behave: Dosing dilemmas for parents of boys with ADHD The American Journal of Bioethics 5 34 47 10.1080/15265160590945129 (Pubitemid 41653987)
67. Hardy, R. 2009. In my dreams, she forgives me. The Daily Mail. Accessed 6 December 2009.
68. R Cools SJ Lewis L Clark RA Barker TW Robbins 2007 L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease Neuropsychopharmacology 32 180 189 10.1038/sj.npp.1301153 (Pubitemid 44967796)
69. A Bechara 2005 Decision making, impulse control and loss of willpower to resist drugs: A neurocognitive perspective Nature Neuroscience 8 1458 1463 10.1038/nn1584 (Pubitemid 41573656)
70. G Thorens Y Khazaal J Billieux M Van der Linden D Zullino 2009 Swiss psychiatrists' beliefs and attitudes about internet addiction The Psychiatric Quarterly 80 117 123 10.1007/s11126-009-9098-2
71. HG Prigerson MJ Horowitz SC Jacobs CM Parkes M Aslan K Goodkin B Raphael SJ Marwit C Wortman RA Neimeyer G Bonanno SD Block D Kissane P Boelen A Maercker BT Litz JG Johnson MB First PK Maciejewski 2009 Prolonged grief disorder: Psychometric validation of criteria proposed for DSM-V and ICD-11 PLoS Medicine 6 e1000121 10.1371/journal.pmed.1000121
72. M Avanzi M Baratti S Cabrini E Uber G Brighetti F Bonfa 2008 The thrill of reckless driving in patients with Parkinson's disease: An additional behavioural phenomenon in dopamine dysregulation syndrome? Parkinsonism and Related Disorders 14 257 258 10.1016/j.parkreldis.2007.04.006 (Pubitemid 351458416)
73. EC Sophia H Tavares MP Berti AP Pereira A Lorena C Mello C Gorenstein ML Zilberman 2009 Pathological love: Impulsivity, personality, and romantic relationship CNS Spectrums 14 268 274
74. C Holden 2001 'Behavioral'addictions: Do they exist? Science 294 980 982 10.1126/science.294.5544.980 (Pubitemid 33041833)
75. MN Potenza 2006 Should addictive disorders include non-substance-related conditions? Addiction 101 Suppl 1 142 151 10.1111/j.1360-0443.2006.01591.x (Pubitemid 44199506)
76. ND Volkow CP O'Brien 2007 Issues for DSM-V: Should obesity be included as a brain disorder? The American Journal of Psychiatry 164 708 710 10.1176/appi.ajp.164.5.708 (Pubitemid 46808521)
77. Carter, A., B. Capps, and W. Hall. 2009. Addiction neurobiology: Ethical and social implications. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
78. A Carter W Hall 2007 The social implications of neurobiological explanations of resistible compulsions The American Journal of Bioethics 7 15 17 10.1080/15265160601064025
79. W Hall L Carter KI Morley 2004 Neuroscience research on the addictions: A prospectus for future ethical and policy analysis Addictive Behaviors 29 1481 1495 10.1016/j.addbeh.2004.06.001 (Pubitemid 39166000)
80. Satel, S., and S. Lilenfeld. 2007. Medical misnomer: Addiction isn't a brain disease, Congress. Slate. http://www.slate.com/id/2171131/nav/navoa/. Accessed 2 August 2007.
81. Sheridan, M. 2009. China's parents try shock therapy to cure net 'addicts'. The Sunday Times. http://www.timesonline.co.uk/tol/news/world/ article6445982.ece. Accessed 6 November 2009.
82. Branidan, T. 2009. China bans electric shock treatment used to 'cure' young internet addicts. The Guardian. http://www.guardian.co.uk/world/2009/jul/ 14/china-electric-shock-internet-addiction. Accessed 6 December 2009.
83. P Conrad 1992 Medicalization and social control Annual Review of Sociology 18 209 232 10.1146/annurev.so.18.080192.001233
84. C Dackis C O'Brien 2005 Neurobiology of addiction: Treatment and public policy ramifications Nature Neuroscience 8 1431 1436 10.1038/nn1105-1431 (Pubitemid 41573650)
85. ND Volkow T-K Li 2005 Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences Pharmacology & Therapeutics 108 3 17 10.1016/j.pharmthera.2005.06.021 (Pubitemid 41379395)
86. D Buchman PB Reiner 2009 Stigma and addiction: Being and becoming The American Journal of Bioethics 9 18 19 10.1080/15265160903090066
87. J Read 2007 Why promoting biological ideology increases prejudice against people labelled "schizophrenic" Australian Psychologist 42 118 128 10.1080/00050060701280607
88. A Goodman 2008 Neurobiology of addiction: An integrative review Biochemical Pharmacology 75 266 322 10.1016/j.bcp.2007.07.030 (Pubitemid 350245486)
89. J-P Tassin 2008 Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse Biochemical Pharmacology 75 85 97 10.1016/j.bcp.2007.06.038 (Pubitemid 350245487)
90. RA Chambers MN Potenza 2003 Neurodevelopment, impulsivity, and adolescent gambling Journal of Gambling Studies 19 53 84 10.1023/A:1021275130071 (Pubitemid 39022548)